News
Academy
Editorial PodcastsEditorial VideosProfiles in Medicine
Conference CoverageConference Listing
Pharmaceutical Executive
Partner Perspectives
Content Engagement HubsE-BooksEventsSponsored PodcastsSponsored VideosWebcastsWhitepapers
Subscribe
Corporate CommunicationsCorporate CommunicationsCorporate CommunicationsCorporate CommunicationsCorporate Communications
Direct-to-ConsumerDirect-to-ConsumerDirect-to-ConsumerDirect-to-Consumer
Emerging BiopharmaEmerging BiopharmaEmerging Biopharma
IR Licensing and PartnershipsIR Licensing and PartnershipsIR Licensing and Partnerships
Market AccessMarket AccessMarket AccessMarket Access
Medical AffairsMedical AffairsMedical AffairsMedical Affairs
OperationsOperationsOperationsOperationsOperations
Patient EngagementPatient Engagement
RegulatoryRegulatoryRegulatoryRegulatory
Sales & MarketingSales & MarketingSales & MarketingSales & MarketingSales & Marketing
Spotlight -
  • Pharmaceutical Executive APEX Awards
  • Latest Executive Roundtables
  • Asembia 2025
IS1
  • Applied Clinical Trials

  • BioPharm International

  • Cannabis Science and Technology

  • Chromatography Online

  • Nutritional Outlook

  • Pharmaceutical Commerce

  • Pharmaceutical Executive

  • Pharm Tech

  • Spectroscopy Online

  • Turbo Machinery Magazine

Corporate CommunicationsCorporate CommunicationsCorporate CommunicationsCorporate CommunicationsCorporate Communications
Direct-to-ConsumerDirect-to-ConsumerDirect-to-ConsumerDirect-to-Consumer
Emerging BiopharmaEmerging BiopharmaEmerging Biopharma
IR Licensing and PartnershipsIR Licensing and PartnershipsIR Licensing and Partnerships
Market AccessMarket AccessMarket AccessMarket Access
Medical AffairsMedical AffairsMedical AffairsMedical Affairs
OperationsOperationsOperationsOperationsOperations
Patient EngagementPatient Engagement
RegulatoryRegulatoryRegulatoryRegulatory
Sales & MarketingSales & MarketingSales & MarketingSales & MarketingSales & Marketing
IS1
  • Applied Clinical Trials

  • BioPharm International

  • Cannabis Science and Technology

  • Chromatography Online

  • Nutritional Outlook

  • Pharmaceutical Commerce

  • Pharmaceutical Executive

  • Pharm Tech

  • Spectroscopy Online

  • Turbo Machinery Magazine

    • Academy
    • Partner Perspectives
    • Subscribe
Advertisement

Beyond Images: 2024 Trends Reshaping Healthcare with Radiopharmaceuticals

February 5, 2024
By Jon Devries
Commentary
Article

By capitalizing on AI advancements, pushing the boundaries of personalized medicine with theranostics, and strengthening digital healthcare networks, radiopharmaceuticals are poised to transform healthcare from a reactive to a proactive discipline.

Image credit: Наталья Евтехова | stock.adobe.com

Image credit: Наталья Евтехова | stock.adobe.com

The healthcare sector is advancing rapidly, with radiopharmaceuticals at the forefront of cancer treatment. These radioactive compounds are extremely effective in both diagnosing and offering targeted therapy, heralding an era of personalized medicine. In this piece, we explore significant trends redefining the possibilities in this field with the potential to improve patient outcomes, streamline provider workflows, and optimize health system efficiency.

Enhancing Efficiency with AI Integration

Radiologists, grappling with increasing workloads and tight deadlines, are increasingly experiencing burnout that can impact patient care. In fact, a staggering 54% reported feeling burnout in 2022, up from 49% the previous year.

AI-driven software addresses this by processing exams, identifying key findings, and automating routine tasks. This not only boosts radiologist efficiency but also enhances patient care by enabling more accurate and faster diagnoses. The reduced time spent on administrative tasks allows radiologists more time for patient consultation, improving the overall healthcare experience.

Theranostics: Innovating Diagnosis and Treatment

Theranostics, which combines diagnostic and therapeutic capabilities, is transforming the approach to diseases such as prostate cancer. This method delivers targeted radiation therapy, minimizing harm to healthy tissues.

Its application extends beyond cancer, showing potential in addressing neurological conditions such as Alzheimer disease and various inflammatory diseases. Theranostics epitomizes the future of personalized medicine, offering treatments that are uniquely tailored to each patient’s biological and disease profile, offering the potential to significantly improve patient outcomes.

Expanding the Digital Framework in Healthcare

Although DICOM has been instrumental in standardizing medical image sharing, contemporary healthcare requires a more comprehensive digital infrastructure. Emerging platforms are integrating diverse data types, including radiopharmaceutical information, laboratory results, and clinical notes.

This amalgamation creates a detailed and holistic patient profile, assisting healthcare professionals across specialties in making well-informed decisions. For example, surgeons can leverage radiopharmaceutical data for intricate tumor resections, and oncologists can devise personalized treatment plans, thereby improving patient care and outcomes. These digital advancements facilitate global collaboration, extending state-of-the-art care to even the most remote locations.

Health Equity

The COVID-19 pandemic has underscored the importance of health equity, and radiology is no exception. A study published by Boston Medical Center showed that Black patients face delays in Alzheimer diagnoses compared to white and Hispanic patients.

Lead author Joshua Wibecan, MD, noted that, “obtaining access to neuroimaging is one possible barrier that delays diagnosis.” Black patients received imaging for cognitive impairment at an older age and were more likely to receive a CT scan, as opposed to the more detailed MRI.

The need for greater diversity and inclusion is crucial, highlighting the importance of collecting more comprehensive gender data to better support patients. Addressing these inequities by ensuring equitable access to advanced imaging technologies, such as MRI, is crucial in delivering timely and accurate diagnoses to all patient groups, improving treatment outcomes.

Looking Ahead: Radiopharmaceuticals Shaping Future Healthcare

These trends highlight the significant role radiopharmaceuticals could play in the future of healthcare. However, ensuring equitable access to these technologies and integrating AI in a manner that benefits all communities remain critical challenges.

By capitalizing on AI advancements, pushing the boundaries of personalized medicine with theranostics, and strengthening digital healthcare networks, radiopharmaceuticals are poised to transform healthcare from a reactive to a proactive discipline. This evolution promises a future in which prevention, diagnosis, and treatment are intricately tailored to each individual’s specific needs.

The result is a healthcare landscape that is not only more effective but also more humane and inclusive, ultimately leading to better patient care, an empowered healthcare workforce, and potentially lower overall healthcare costs.

About the Author

Jon DeVries is the CEO of Mirada Medical and has more than 20 years of experience spearheading the creation and release of innovative cloud-based healthcare initiatives that bring advanced services and technologies to providers and researchers, with the goal of improving patient care. Mirada’s technology plays an integral role in the medical practice, TeleDaaS, revolutionizing the radiopharmaceutical industry by providing dosimetry-as-a-service.

Recent Videos
Ted Sweetser
Ted Sweetser
Ted Sweetser
Related Content

Stock.adobe.com

DeepL Announces HIPPA-Compliant AI

Mike Hollan
May 15th 2025
Article

The protection and privacy of healthcare data is a massive hurdle for the new technology to overcome.


Revolutionizing Patient Adherence: Leveraging AI for Personalized Engagement

Revolutionizing Patient Adherence: Leveraging AI for Personalized Engagement

Miranda Schmalfuhs
February 10th 2025
Podcast

Bill Grambley, CEO of AllazoHealth, delves into the potential of AI to revolutionize patient engagement and adherence.


Earned Media and ASCO: Provide Context Beyond the Data

Earned Media and ASCO: Provide Context Beyond the Data

Michael Christel
May 13th 2025
Article

The latest Q&A installment in Pharm Exec's earned media series details key strategies for leveraging breaking news at industry trade shows, including the upcoming American Society of Clinical Oncology (ASCO) Annual Meeting.


Cell and Gene Therapy Check-in 2024

Cell and Gene Therapy Check-in 2024

Miranda Schmalfuhs
January 18th 2024
Podcast

Fran Gregory, VP of Emerging Therapies, Cardinal Health discusses her career, how both CAR-T therapies and personalization have been gaining momentum and what kind of progress we expect to see from them, some of the biggest hurdles facing their section of the industry, the importance of patient advocacy and so much more.


Revenue Optimization: The Money Matters—That Matter Most

Revenue Optimization: The Money Matters—That Matter Most

Jesse Mendelsohn
May 9th 2025
Article

Navigating technology and regulatory shifts in pharma revenue management.


Stock.adobe.com

Blue Cross Blue Shield of Massachusetts Adds Virtual-First Primary Care Option

Mike Hollan
May 9th 2025
Article

The provider hopes that this option will be a solution to the state’s primary care physician shortage.

Related Content

Stock.adobe.com

DeepL Announces HIPPA-Compliant AI

Mike Hollan
May 15th 2025
Article

The protection and privacy of healthcare data is a massive hurdle for the new technology to overcome.


Revolutionizing Patient Adherence: Leveraging AI for Personalized Engagement

Revolutionizing Patient Adherence: Leveraging AI for Personalized Engagement

Miranda Schmalfuhs
February 10th 2025
Podcast

Bill Grambley, CEO of AllazoHealth, delves into the potential of AI to revolutionize patient engagement and adherence.


Earned Media and ASCO: Provide Context Beyond the Data

Earned Media and ASCO: Provide Context Beyond the Data

Michael Christel
May 13th 2025
Article

The latest Q&A installment in Pharm Exec's earned media series details key strategies for leveraging breaking news at industry trade shows, including the upcoming American Society of Clinical Oncology (ASCO) Annual Meeting.


Cell and Gene Therapy Check-in 2024

Cell and Gene Therapy Check-in 2024

Miranda Schmalfuhs
January 18th 2024
Podcast

Fran Gregory, VP of Emerging Therapies, Cardinal Health discusses her career, how both CAR-T therapies and personalization have been gaining momentum and what kind of progress we expect to see from them, some of the biggest hurdles facing their section of the industry, the importance of patient advocacy and so much more.


Revenue Optimization: The Money Matters—That Matter Most

Revenue Optimization: The Money Matters—That Matter Most

Jesse Mendelsohn
May 9th 2025
Article

Navigating technology and regulatory shifts in pharma revenue management.


Stock.adobe.com

Blue Cross Blue Shield of Massachusetts Adds Virtual-First Primary Care Option

Mike Hollan
May 9th 2025
Article

The provider hopes that this option will be a solution to the state’s primary care physician shortage.

About
Advertise
Contact Us
Editorial Board
Editorial Submission Guidelines
Do Not Sell My Personal Information
Privacy Policy
Terms and Conditions
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.